Business Name: |
Obiefuna Nkechinyere MD |
Contact Person: |
Nkechinyere Obiefuna |
Address: |
355 Grand St, Jersey City, New Jersey 07302 |
Phone Number: |
(201) 915-2000 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Marquis Rebekah J DO - Jersey City, NJ 07302 Loskove Joseph A MD - Jersey City, NJ 07302 Joshi Aditi U MD - Jersey City, NJ 07302 Forsythe Michael J MD - Jersey City, NJ 07302 Hsu Hanson MD - Jersey City, NJ 07302 Blomberg Adam L MD - Jersey City, NJ 07302 Boolbol Joseph J MD - Jersey City, NJ 07302 Freedman Jessica F MD - Jersey City, NJ 07302 Cholankeril John MD - Jersey City, NJ 07302 Medrano D N MD - Jersey City, NJ 07302 Smith Arthur A MD - Jersey City, NJ 07302 Patel Amit V MD - Jersey City, NJ 07302 Chun John MD - Jersey City, NJ 07302 Ghimire Shanker MD - Jersey City, NJ 07302 Romero Melchor D MD - Jersey City, NJ 07302 Shipley Neal MD - Jersey City, NJ 07302 Schrag Sherwin P MD - Jersey City, NJ 07302 Hamid Iqbal Z MD - Jersey City, NJ 07302 Montague Skiles A MD - Jersey City, NJ 07302 Doherty Maureen A DO - Jersey City, NJ 07302 |
The company Obiefuna Nkechinyere MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Obiefuna Nkechinyere MD, and the business now earns $500.000 to $999.999 per annum.
Obiefuna Nkechinyere MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Obiefuna Nkechinyere MD, please call Nkechinyere Obiefuna with the phone number (201) 915-2000 or visit its single location at 355 Grand St in Jersey City, New Jersey 07302.
The location of the single location can also be found using the coordinates 40.71665,-74.05065.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.